These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8974018)

  • 1. Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemia.
    Córdoba-Porras A; Sánchez-Quesada JL; González-Sastre F; Ordóñez-Llanos J; Blanco-Vaca F
    J Mol Med (Berl); 1996 Dec; 74(12):771-6. PubMed ID: 8974018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.
    Ben-Ari Z; Tur-Kaspa R; Schafer Z; Baruch Y; Sulkes J; Atzmon O; Greenberg A; Levi N; Fainaru M
    J Investig Med; 2001 Jul; 49(4):325-9. PubMed ID: 11478408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein.
    Halvorsen B; Brude I; Drevon CA; Nysom J; Ose L; Christiansen EN; Nenseter MS
    J Lipid Res; 1996 Jul; 37(7):1591-600. PubMed ID: 8827529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.
    Blom HJ; Kleinveld HA; Boers GH; Demacker PN; Hak-Lemmers HL; Te Poele-Pothoff MT; Trijbels JM
    Eur J Clin Invest; 1995 Mar; 25(3):149-54. PubMed ID: 7781660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.
    Piolot A; Blache D; Boulet L; Fortin LJ; Dubreuil D; Marcoux C; Davignon J; Lussier-Cacan S
    J Lab Clin Med; 2003 Jan; 141(1):41-9. PubMed ID: 12518167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.
    Belkebir-Mesbah D; Bonnefont-Rousselot D; Frey-Fressart V; Moinard C; Delattre J; Vasson MP
    Endocrine; 1999 Jun; 10(3):233-42. PubMed ID: 10484287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
    Chiu HC; Jeng JR; Shieh SM
    Biochim Biophys Acta; 1994 Jan; 1225(2):200-8. PubMed ID: 8280789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Maturitas; 1998 Jan; 28(3):229-34. PubMed ID: 9571598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients.
    Seo H; Oh H; Park H; Park M; Jang Y; Lee M
    Yonsei Med J; 2010 Jul; 51(4):526-33. PubMed ID: 20499417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults.
    Romerio SC; Linder L; Nyfeler J; Wenk M; Litynsky P; Asmis R; Haefeli WE
    Atherosclerosis; 2004 Oct; 176(2):337-44. PubMed ID: 15380457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Campione AL; Moore MK
    Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical pathology of homocysteine. I. Atherogenesis.
    McCully KS
    Ann Clin Lab Sci; 1993; 23(6):477-93. PubMed ID: 8291902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine strongly enhances metal-catalyzed LDL oxidation in the presence of cystine and cysteine.
    Pfanzagl B; Tribl F; Koller E; Möslinger T
    Atherosclerosis; 2003 May; 168(1):39-48. PubMed ID: 12732385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice].
    Julve J; Errico TL; Chen X; Santos D; Freixa J; Porcel I; Cubero E; Escolà-Gil JC; Blanco-Vaca F
    Clin Investig Arterioscler; 2013; 25(4):164-73. PubMed ID: 23938051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
    Donner MG; Klein GK; Mathes PB; Schwandt P; Richter WO
    Metabolism; 1998 Mar; 47(3):273-9. PubMed ID: 9500562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification.
    Wakatsuki A; Ikenoue N; Okatani Y; Shinohara K; Fukaya T
    Obstet Gynecol; 2000 Jul; 96(1):55-9. PubMed ID: 10862842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.
    Julve J; Escolà-Gil JC; Rodríguez-Millán E; Martín-Campos JM; Jauhiainen M; Quesada H; Rentería-Obregón IM; Osada J; Sánchez-Quesada JL; Blanco-Vaca F
    Mol Nutr Food Res; 2013 Oct; 57(10):1814-24. PubMed ID: 23754667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrate.
    Nagyová A; Raslová K; Ginter E
    Physiol Res; 1998; 47(3):185-90. PubMed ID: 9803483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia, enzyme polymorphism and thiobarbituric Acid reactive system in children with high coronary risk family history.
    Szamosi T; Roth E; Szamosi T; Tomsits E; Tordai A; Szabo T
    J Am Coll Nutr; 2004 Oct; 23(5):386-90. PubMed ID: 15466944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
    Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
    Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.